Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of methoxyetomidate hydrochloride injection for sedation/anesthesia during gastrointestinal endoscopy
CTR20250713Phase 3Completed
- Sponsor
- Horgos Yaoyue Consulting
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methoxyethyl etomidate in None, sponsored by Horgos Yaoyue Consulting. Started Mar 2025; status: completed.
02
Drugs
methoxyethyl etomidate
Beyond the preview
Go deeper on CTR20250713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250713.